First National Bank Of Hutchinson Astrazeneca PLC Transaction History

First National Bank Of Hutchinson

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$64.85 - $71.7 $3,242 - $3,585	50 Added 1.52%	3,348 $226,000
Q2 2023 Jul 27, 2023	BUY	$69.91 - $75.81 $14,191 - $15,389	203 Added 6.56%	3,298 $236,000
Q1 2023 Apr 25, 2023	BUY	$63.15 - $71.6 $1,957 - $2,219	31 Added 1.01%	3,095 $214,000
Q4 2022 Feb 03, 2023	BUY	$54.21 - $70.44 $166,099 - $215,828	3,064 New	3,064 $207,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of First National Bank Of Hutchinson, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Hutchinson with notifications on news.